nuaxia | Blog

Rechercher

nuaxia

il y a 1 jour3 min de lecture

AstraZeneca Expands China Partnerships with Up to $2.1bn Respiratory Drug Deal

nuaxia

il y a 1 jour3 min de lecture

Kalohexis Files Confidentially for IPO to Advance Obesity and Cachexia Pipeline

nuaxia

il y a 1 jour3 min de lecture

Novo Nordisk Explores Long-Acting Semaglutide Implant Through Vivani Partnership

nuaxia

il y a 1 jour3 min de lecture

Biocytogen and Whitehawk Partner to Advance Next-Generation Bispecific ADCs

nuaxia

il y a 1 jour2 min de lecture

FDA advisory panel recommends four peptides for 503A compounding list

nuaxia

il y a 2 jours3 min de lecture

Ottobock Acquires Fesia Technology to Expand Neurorehabilitation Portfolio

nuaxia

il y a 2 jours2 min de lecture

VB Spine Expands Surgical Navigation Portfolio with Augmedics CT-Fluoro Technology Deal

nuaxia

il y a 2 jours3 min de lecture

NICE Recommends First Non-Invasive Endometriosis Diagnostic Tools for NHS Use

nuaxia

il y a 2 jours3 min de lecture

Vertex Acquires Crinetics for $10B to Expand into Endocrinology

nuaxia

il y a 2 jours3 min de lecture

AstraZeneca and Ionis Miss Primary Endpoint in Phase III ATTR-CM Trial for Eplontersen

nuaxia

il y a 2 jours2 min de lecture

FDA Approves Accord BioPharma's ENNUMO Biosimilar to Neulasta

nuaxia

il y a 2 jours3 min de lecture

FDA Clears AI-Powered Diabetic Retinopathy Screening Software from iHealthScreen

nuaxia

il y a 2 jours2 min de lecture

Roche Secures CE Mark for Automated Blood Test to Detect Latent Tuberculosis

nuaxia

il y a 2 jours3 min de lecture

FDA Approves Johnson & Johnson's Dual-Energy Catheter Ablation Platform

nuaxia

il y a 2 jours2 min de lecture

Leo Cancer Care Raises $65m to Expand Upright Radiotherapy Platform

nuaxia

il y a 2 jours3 min de lecture

Forte Biosciences Reports Positive Phase Ib Results for FB102 Vitiligo Treatment

nuaxia

il y a 2 jours3 min de lecture

FDA Approves Subcutaneous Sarclisa (Isatuximab-Irfc) for Multiple Myeloma Treatment

nuaxia

il y a 2 jours3 min de lecture

AtaCor Enrols First Patient in Pivotal Trial of Extravascular ICD System for Cardiac Rhythm Management

nuaxia

il y a 2 jours3 min de lecture

AstraZeneca Licences Sino Biopharmaceutical’s TQC3721 Respiratory Drug in Potential $1.9bn Deal

nuaxia

il y a 2 jours3 min de lecture

AstraZeneca Expands China Partnerships with Up to $2.1bn Respiratory Drug Deal

Kalohexis Files Confidentially for IPO to Advance Obesity and Cachexia Pipeline

Novo Nordisk Explores Long-Acting Semaglutide Implant Through Vivani Partnership

Biocytogen and Whitehawk Partner to Advance Next-Generation Bispecific ADCs

FDA advisory panel recommends four peptides for 503A compounding list

Ottobock Acquires Fesia Technology to Expand Neurorehabilitation Portfolio

VB Spine Expands Surgical Navigation Portfolio with Augmedics CT-Fluoro Technology Deal

NICE Recommends First Non-Invasive Endometriosis Diagnostic Tools for NHS Use

Vertex Acquires Crinetics for $10B to Expand into Endocrinology

AstraZeneca and Ionis Miss Primary Endpoint in Phase III ATTR-CM Trial for Eplontersen

FDA Approves Accord BioPharma's ENNUMO Biosimilar to Neulasta

FDA Clears AI-Powered Diabetic Retinopathy Screening Software from iHealthScreen

Roche Secures CE Mark for Automated Blood Test to Detect Latent Tuberculosis

FDA Approves Johnson & Johnson's Dual-Energy Catheter Ablation Platform

Leo Cancer Care Raises $65m to Expand Upright Radiotherapy Platform

Forte Biosciences Reports Positive Phase Ib Results for FB102 Vitiligo Treatment

FDA Approves Subcutaneous Sarclisa (Isatuximab-Irfc) for Multiple Myeloma Treatment

AtaCor Enrols First Patient in Pivotal Trial of Extravascular ICD System for Cardiac Rhythm Management

AstraZeneca Licences Sino Biopharmaceutical’s TQC3721 Respiratory Drug in Potential $1.9bn Deal

Sanofi’s Sarclisa Escena Receives FDA Approval as First Oncology Drug Delivered Through On-Body Injector